Related Experiment Video
Updated: Jun 26, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Dual antiplatelet therapy is an effective treatment method after coronary artery endarterectomy: a single-centre
Yalçın Günerhan1, Mehmet Işık1, Serkan Yıldırım1
1Department of Cardiovascular Surgery, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Insights
Dual antiplatelet therapy (DAPT) effectively manages outcomes after coronary artery bypass grafting with endarterectomy (CABG-CE). This study evaluated early postoperative acute coronary syndrome, mortality, and morbidity in CABG-CE patients receiving DAPT.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- Coronary artery bypass grafting with endarterectomy (CABG-CE) is a complex procedure.
- Postoperative management, including dual antiplatelet therapy (DAPT), is crucial for patient outcomes.
- Limited data exists on the early postoperative period following CABG-CE with DAPT.
Purpose of the Study:
- To investigate the early postoperative outcomes of patients undergoing CABG-CE.
- To assess the incidence of acute coronary syndrome, mortality, and morbidity in this cohort.
- To evaluate the effectiveness of DAPT in the early postoperative period after CABG-CE.
Main Methods:
- A retrospective study of 99 patients who underwent CABG-CE between 2022 and 2024.
- Postoperative DAPT was administered to all included patients.
- Preoperative and postoperative ECG, echocardiography (Echo), ejection fraction (EF) changes, operative time, 30-day mortality, and ICU length of stay were analyzed.
Main Results:
- Left anterior descending (LAD) endarterectomy (38.4%) was associated with myocardial infarction (MI) in 8 patients and arrhythmia in 8 patients, with 2 mortalities.
- Right coronary artery (RCA) endarterectomy (38.4%) showed 2 ECG changes, 9 arrhythmias, and 2 mortalities.
- Circumflex artery (CX) endarterectomy (12.1%) resulted in 3 ECG changes, 5 arrhythmias, and 2 mortalities. Longer cross-clamping time was noted for LAD endarterectomy. Mean ICU stay was 4.0 ± 4.5 days.
Conclusions:
- Dual antiplatelet therapy (DAPT) demonstrates effectiveness in the early postoperative period following CABG-CE.
- DAPT is particularly beneficial for patients with diabetes mellitus (DM), diffuse, long-segment, or calcified plaques.
- The findings support the use of DAPT to mitigate early complications after CABG-CE.
Aim:
It was aimed to investigate the patients who underwent coronary artery bypass grafting with coronary endarterectomy (CABG-CE) and postoperative dual antiplatelet therapy (DAPT) in terms of acute coronary syndrome, mortality and morbidity in the early period.
Method:
Ninety-nine patients who underwent endarterectomy during CABG between 2022 and 2024 were included in the study. DAPT was applied after surgery. Preoperative and postoperative electrocardiogram (ECG), echocardiography (Echo), ejection fraction (EF) changes, operative time, postoperative first 30-day mortality, and length of stay in the intensive care unit (ICU) were investigated.
Result:
The left anterior descending (LAD) coronary artery endarterectomy rate was 38.4%. Among those who underwent LAD endarterectomy, eight had ECG changes in favour of myocardial infarction (MI), eight had postoperative arrhythmia, and two had mortality. The right coronary artery (RCA) endarterectomy rate was 38.4%. Of these cases, two had ECG changes, nine had postoperative arrhythmia, and two hadmortality. The circumflex artery (CX) endarterectomy rate was 12.1%. Of these, three had ECG changes, five had postoperative arrhythmia, and two had mortality. Although the bypass numbers were equal, the cross-clamping time was longer in patients who underwent LAD endarterectomy than in those who underwent RCA or CX endarterectomy. The postoperative blood replacement requirement was 1.6 ± 1.4 units. The mean length of stay in the ICU was 4.0 ± 4.5 days.
Conclusions:
DAPT is an effective treatment method after CABG-CE surgery, especially for patients with diabetes mellitus (DM) and coronary artery disease and diffuse, long-segment, calcified plaque.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care